Press Releases from Anergis SA (4 total)
Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Lik …
- Study is performed at the Helmholtz Centre for Infection Research and supported by a TRANSVAC2 grant -
Epalinges, Switzerland, July 09, 2020 – Anergis SA,…
Anergis Reports Positive Preclinical Proof-of Concept Data of the Second-Generat …
- The second-generation COP Allergy Vaccines met the preset success criteria: strong TH1 response, absence of IgE response and excellent tolerability
- Anergis will…
Anergis Appoints Jacques-François Martin as Chairman of the Board of Directors
EPALINGES, Switzerland – February 1st, 2012 – Anergis, a clinical-stage biopharmaceutical company developing novel allergy vaccines, today announced the appointment of Jacques-François Martin, Chairman and…
Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative …
LAUSANNE, Switzerland – March 28th, 2011 – Anergis SA announced today that it has closed a Series A financing round raising CHF 18 millions from…
Go To Page:
